Structure via PubChem · Public domain (PubChem)
OverviewAI-generated
Capreomycin is a chemical substance identified by the NCI Thesaurus ID C72607. It is indexed in PubMed, where a query for the term yields 823 results.
In the PubChem database, capreomycin is assigned the CID 135483770. Its InChIKey is VCOPTHOUUNAYKQ-WBTCAYNUSA-N. The molecule has a topological polar surface area (TPSA) of 737. It contains 27 hydrogen bond donors and 23 hydrogen bond acceptors.
Synthesized by Vinony from 8 facts across 3 sources: Wikidata, PubMed, PubChem. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
In the Vinony graph
Vinony's link graph records 90 inbound references to capreomicina, and connects out to 4-aminosalicylic acid, antibiotic and tuberculosis management.
It sits within the topics Anti-tuberculosis drugs, Drugs with no legal status and Polypeptide antibiotics.
Vinony links it to 23 Wikipedia language editions.
Key facts
- Drug.image
- Capreomycin IA.svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Capreomycin IB.svg
- Drug.image_class2
- skin-invert-image
- Drug.tradename
- Capastat
- Drug.MedlinePlus
- a682860
- Drug.routes_of_administration
- Intramuscular
- Drug.ATC_prefix
- J04
- Drug.ATC_suffix
- AB30
- Drug.CAS_number
- 11003-38-6
- Drug.PubChem
- 3000502
- Drug.DrugBank
- DB00314
- Drug.ChemSpiderID
- 2272094
- Drug.UNII
- 232HYX66HC
- Drug.KEGG
- D07607
- Drug.ChEMBL
- 2221250
- Drug.NIAID_ChemDB
- 007653
- Drug.IUPAC_name
- (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide; (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide | C=25 | H=44 | N=14 | O=8 | SMILES = C[C@H]1C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N[C@H](C(=O)NC[C@@H](C(=O)N1)N)[C@H]2CCN=C(N2)N)CNC(=O)C[C@H](CCCN)N.C1CN=C(N[C@H]1[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N2)CNC(=O)C[C@H](CCCN)N)CO)N)N | StdInChI = 1S/C25H44N14O8.C25H44N14O7/c26-4-1-2-11(27)6-17(41)32-8-14-20(43)35-15(9-34-25(30)47)21(44)39-18(13-3-5-31-24(29)38-13)23(46)33-7-12(28)19(42)37-16(10-40)22(45)36-14;1-11-19(41)36-15(9-32-17(40)7-12(27)3-2-5-26)21(43)37-16(10-34-25(30)46)22(44)39-18(14-4-6-31-24(29)38-14)23(45)33-8-13(28)20(42)35-11/h9,11-14,16,18,40H,1-8,10,26-28H2,(H,32,41)(H,33,46)(H,35,43)(H,36,45)(H,37,42)(H,39,44)(H3,29,31,38)(H3,30,34,47);10-15,18H,2-9,26-28H2,1H3,(H,32,40)(H,33,45)(H,35,42)(H,36,41)(H,37,43)(H,39,44)(H3,29,31,38)(H3,30,34,46)/b15-9+;16-10+/t11-,12-,13+,14-,16-,18-;11-,12-,13-,14+,15-,18-/m00/s1 | StdInChIKey = VCOPTHOUUNAYKQ-WBTCAYNUSA-N | density = | density_notes = | melting_point = | melting_high = | melting_notes = | boiling_point = | boiling_notes = | solubility = | sol_units = | specific_rotation =
via Wikipedia infobox
Chemical data
- Formula
- C50H88N28O15
- Molecular weight
- 1321.4 g/mol
- IUPAC name
- (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide
- SMILES
- C[C@H]1C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N[C@H](C(=O)NC[C@@H](C(=O)N1)N)[C@H]2CCNC(=N2)N)CNC(=O)C[C@H](CCCN)N.C1CNC(=N[C@H]1[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N2)CNC(=O)C[C@H](CCCN)N)CO)N)N
- InChIKey
- VCOPTHOUUNAYKQ-WBTCAYNUSA-N
- Polar surface area
- 737 Ų
- H-bond donors
- 27
- H-bond acceptors
- 23
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Molecule type
- Small molecule
via ChEMBL · EBI
Research
823 papers- Capreomycin.2006
- Capreomycin.2012
- Capreomycin.Tuberculosis (Edinburgh, Scotland) · 2008
- Capreomycin.Journal of clinical pathology · 1967
- Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
via PubMed
Wikidata facts
- Instance of
- essential medicine
Show 4 more facts
- NCI Thesaurus ID
- C72607
- defined daily dose
- 1
- medical condition treated
- tuberculosis
- natural product of taxon
- Streptomyces
via Wikidata · CC0
Article · Italiano
La "capreomicina" è un antibiotico naturale isolato per la prima volta nel 1960 dallo streptomyces capreolus. Chimicamente simile alla viomicina è formato da 4 principi attivi A, B, 2A, 2B ed è comunemente associata agli amminoglucosidi.
Abstract from DBpedia / Wikipedia · CC BY-SA